Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Merck Sharp & Dohme LLC
BioNTech SE
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Merck Sharp & Dohme LLC
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Bristol-Myers Squibb
Bayer
Eli Lilly and Company
Pheon Therapeutics
AstraZeneca
Eli Lilly and Company
Pfizer
InSightec
AstraZeneca
AstraZeneca
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
ArriVent BioPharma, Inc.
Kivu Bioscience Inc.
Achieve Life Sciences
ImmunityBio, Inc.
Iovance Biotherapeutics, Inc.
Instil Bio
BeOne Medicines
AstraZeneca
Hummingbird Bioscience
BeOne Medicines
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Exelixis
BeOne Medicines
BioNTech SE
ImmunityBio, Inc.
BioNTech SE
BicycleTx Limited
Bristol-Myers Squibb
Astellas Pharma Inc
Bristol-Myers Squibb
Astellas Pharma Inc
AbbVie
BioNTech SE
Maia Biotechnology
Novartis
OncoC4, Inc.
AstraZeneca
Medicine Invention Design, Inc
Kura Oncology, Inc.